Claude-Eric Bulabois Selected Research

Inflammation (Inflammations)

1/2019

Multi-organ failure induced by Nivolumab in the context of allo-stem cell transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Claude-Eric Bulabois Research Topics

Disease

10	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2023 - 12/2012
6	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2024 - 10/2002
5	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023 - 12/2012
4	Multiple Myeloma 08/2023 - 08/2015
4	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 12/2007
3	Leukemia 07/2023 - 05/2015
3	Bronchiolitis Obliterans Syndrome 01/2023 - 05/2015
3	Lymphoma (Lymphomas) 11/2021 - 05/2008
2	Hemorrhagic Cystitis 10/2021 - 10/2002
2	Neoplasms (Cancer) 01/2019 - 12/2007
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2008 - 12/2007
1	Thrombotic Microangiopathies 04/2024
1	VEXAS syndrome 02/2024
1	T-Cell Lymphoma (Lymphoma, T Cell) 11/2021
1	Cystitis 10/2021
1	Hematuria 10/2021
1	Wounds and Injuries (Trauma) 01/2019
1	Inflammation (Inflammations) 01/2019
1	Polymyositis 01/2019
1	Hodgkin Disease (Hodgkin's Disease) 01/2019
1	Transfusion Reaction 04/2018
1	Hematologic Diseases (Blood Diseases) 04/2018
1	Thrombocytopenia (Thrombopenia) 04/2018
1	Renal Insufficiency (Renal Failure) 01/2018
1	Sarcoidosis (Schaumann Disease) 09/2016
1	Essential Thrombocythemia 05/2015
1	Residual Neoplasm 03/2013
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 06/2010
1	Pathologic Complete Response 01/2010
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2010
1	Infections 01/2009
1	Toxoplasmosis 01/2009
1	Thrombosis (Thrombus) 10/2008
1	Hemorrhage 10/2008
1	Second Primary Neoplasms (Neoplasms, Second) 12/2007
1	Aspergillosis 10/2005
1	Virus Diseases (Viral Diseases) 10/2002
1	Disease Progression 10/2002

Drug/Important Bio-Agent (IBA)

5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2024 - 10/2002
3	SteroidsIBA 08/2023 - 01/2019
3	Busulfan (Busulfex)FDA Link 11/2016 - 10/2002
2	fludarabineIBA 11/2016 - 05/2015
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 05/2015 - 05/2014
1	eculizumab FDA Link 04/2024
1	AntigensIBA 07/2023
1	Prednisone (Sone)FDA LinkGeneric 01/2023
1	nilotinib FDA Link 01/2023
1	ibrutinibIBA 01/2023
1	Imatinib Mesylate (Gleevec)FDA Link 01/2023
1	Peroxidase (Myeloperoxidase)IBA 05/2021
1	Decitabine FDA Link 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	NivolumabIBA 01/2019
1	HLA-DRB3 Chains (HLA DRB3)IBA 05/2018
1	amotosalenIBA 04/2018
1	Hemostatics (Antihemorrhagics)IBA 04/2018
1	SolutionsIBA 04/2018
1	Melphalan (Alkeran)FDA LinkGeneric 01/2018
1	Clofarabine (Clolar)FDA Link 11/2016
1	CalreticulinIBA 05/2015
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 05/2015
1	Core Binding Factors (Core-Binding Factor)IBA 03/2013
1	Azacitidine (5 Azacytidine)FDA Link 12/2012
1	Immunoglobulin M (IgM)IBA 01/2009
1	DNA (Deoxyribonucleic Acid)IBA 01/2009
1	Fibrinogen (Factor I)FDA Link 10/2008
1	Asparaginase (Elspar)FDA Link 10/2008
1	AntithrombinsIBA 10/2008
1	Cytotoxins (Cytolysins)IBA 12/2007
1	Dihydrotachysterol (AT 10)IBA 12/2007
1	galactomannanIBA 10/2005
1	Factor XIII (Coagulation Factor XIII)IBA 10/2002

Therapy/Procedure

14	Stem Cell Transplantation 01/2023 - 10/2002
9	Hematopoietic Stem Cell Transplantation 01/2024 - 01/2009
9	Therapeutics 08/2023 - 05/2008
7	Transplantation 04/2024 - 12/2007
2	Cell Transplantation 02/2024 - 12/2023
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2023 - 05/2014
2	Salvage Therapy 01/2023 - 01/2023
2	Drug Therapy (Chemotherapy) 11/2021 - 01/2021
1	Haploidentical Transplantation 01/2019
1	Autologous Transplantation 01/2018
1	Induction Chemotherapy 10/2008
1	Injections 10/2008